(EMAILWIRE.COM, October 26, 2018 ) Infectious Diseases Diagnostics Market Size is anticipated to grow at a 7.9% CAGR from 2018 to 2023 and it is estimated that the global market was valued at USD 16.82 billion in 2018 and is relied upon to achieve USD 24.6 billion by 2023. Infectious disease diagnostics involves various method to check for the presence of foreign antigen/organism with the help of numerous diagnostic tools. Infectious disease conditions are highly widespread in under developed regions owing to the lack of awareness for personal hygiene, minimal health care expenditures, and absence of efficient physician services. Rising cases of infectious diseases in developed economies is further expected to boost the market growth. This has lead vitro diagnostic device manufacturers to invest into emerging economies. These companies are taking efforts to develop and commercialize cost effective tools for the infectious disease diagnosis.

Infectious Diseases Diagnostics Market Growth and Restraints

Disease diagnostics are used for confirmation of a disease in form of a quick, precise test result. Being time consuming, disease diagnostics are on a rise. The infectious disease epidemics are spreading worldwide, thereby leading to an increase in demand of diagnostic tests. In addition, the incidences of malaria, flu, AIDS, and other diseases are also on a rise, creating a robust demand for infectious disease diagnostics. With a majority of physicians adopting the evidence-based treatment method, infectious disease diagnostic kits are more likely to gain traction over the forecast period. Several government-funded programs all over the globe are increasingly providing free screening and tests in order to increase awareness, accurately diagnose diseases, and minimize the chances of infection. Such initiatives are anticipated to boost the market growth in the next few years. However, diagnostic kits are expensive and manufacturers still have a poor distribution channel for operating across emerging economies. These two factors are projected to be the key challenges to rapid revenue growth of the global infectious diseases diagnostics market.

Infectious Diseases Diagnostics Market Segmentation by Product, Application, Technology and End User. On the basis of Product, it is segmented into Instruments, Reagents, Services, and Software. Consumables accounted for the largest share. On the basis of Application, it is segmented into Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus (HPV), Methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola, Typhoid, Malaria, and Dengue) included. Hospital-acquired MRSA infections and human papillomavirus (HPV) are expected to be the fastest-growing market segments in the forecast period. On the basis of technology, it is segmented into PCR, INAAT, DNA Sequencing and Hybridization. Traditional methods are categorized into immunodiagnostics, microscopy, and biochemical characterization. Microarrays and INAAT are projected to witness the highest growth during the forecast period. This noteworthy growth can be accredited to the specificity and an increase in the efficiency of these tests. On the basis of End User, it is segmented into Hospital and Laboratories. Hospital laboratories and reference labs held the largest share in this market segment.

Infectious Diseases Diagnostics Market geographical segmentation by North America, Europe, Asia-Pacific and Middle East and Africa. North America held the largest share of the IDD market, followed by Europe. Both regions are projected to witness single-digit growth rates during the coming years. Be that as it may, Asia-Pacific is projected to register the highest growth rate in the coming years, due to the high pervasiveness of infectious diseases, and huge investment opportunities due to a growth in healthcare expenditure.

Infectious Disease Diagnostics Market Technological Scenario

Over the last two decades, the volume of testing performed outside of the laboratories has been growing, driven by the increasing need to deliver care closer to the patient. During the last few years, the number of tests that are performed using the PoC devices has expanded significantly. Point of Care diagnostic tests for the infectious diseases are mainly based on antibody and microbial particle detection methods that includes optical immunoassays, enzyme-linked immunosorbence, agglutination, and lateral flow immunochromatography. These infectious disease tests based on PoC can detect a variety of infections causing microorganisms from patient samples

In the area of infectious diseases whereas existing LFS technology is not sensitive and a new molecular techniques have seen as the future of PoCT, both in the developed and developing world. Point of Care Test devices that uses PCR technology to discover a number of pathogens are just starting to appear and can be used in near future.

In recent years, microfluidic technologies have also shown a major growth in applications in the field of infectious disease diagnostics. This technology-based instrumentation has shown promising results in many of the laboratory techniques, including nucleic-acid amplification tests, blood chemistries, flow cytometry and immunoassays.

Free sample: https://www.marketdataforecast.com/market-reports/infectious-diseases-diagnostics-market-4607/request-sample

Infectious Diseases Diagnostics Market Key Players

The major Infectious Diseases Diagnostics Market leaders are Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher Corporation, SBecton, Dickinson and Company, Cepheid, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.

Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: 18887029626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results